33,547 Shares in BlackRock Capital Allocation Term Trust $BCAT Bought by Joseph P. Lucia & Associates LLC

Joseph P. Lucia & Associates LLC acquired a new position in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) in the second quarter, HoldingsChannel reports. The institutional investor acquired 33,547 shares of the company’s stock, valued at approximately $534,000.

Several other institutional investors have also recently added to or reduced their stakes in BCAT. Geneos Wealth Management Inc. raised its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after purchasing an additional 1,582 shares during the period. N.E.W. Advisory Services LLC boosted its holdings in shares of BlackRock Capital Allocation Term Trust by 100.0% in the 4th quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after buying an additional 1,200 shares during the period. McIlrath & Eck LLC grew its position in shares of BlackRock Capital Allocation Term Trust by 169.6% during the 1st quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock valued at $44,000 after buying an additional 1,969 shares during the last quarter. Parallel Advisors LLC bought a new stake in shares of BlackRock Capital Allocation Term Trust during the 3rd quarter valued at about $47,000. Finally, Brown Brothers Harriman & Co. raised its stake in BlackRock Capital Allocation Term Trust by 450.0% during the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock worth $81,000 after acquiring an additional 4,500 shares during the period. Institutional investors own 36.12% of the company’s stock.

BlackRock Capital Allocation Term Trust Price Performance

Shares of NYSE BCAT opened at $15.77 on Tuesday. The firm’s 50-day moving average price is $15.79 and its two-hundred day moving average price is $15.28. BlackRock Capital Allocation Term Trust has a 52-week low of $13.73 and a 52-week high of $16.20.

BlackRock Capital Allocation Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.2542 per share. This represents a c) dividend on an annualized basis and a dividend yield of 19.3%. The ex-dividend date is Tuesday, September 15th.

BlackRock Capital Allocation Term Trust Profile

(Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

Read More

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.